LifebankUSA is a business unit of Celgene Corporation.
Celgene Corporation is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases. It was founded in 1986, became publicly traded in 1987 (NASDAQ: CELG), and today boasts a market capitalization of over $5 billion.
As a member of NASDAQ, Celgene reportes its earnings and profits to the Securities and Exchange Commission, and is subject to audits. This information may be of importance as physicians and clients consider the stability of the companies with which they consider banking. Celgene is both profitable and stable, which are two attributes that most prospective clients find appealing.
For more information visit www.celgene.com.
LifebankUSA™, A Celgene Company. Copyright © 2007